Asia-Pacific Roundup: NMPA adopts policy to cut time between drug approval and market supply in China

RoundupsRoundupsAsiaBiologics/ biosimilars/ vaccinesMedical DevicesOceaniaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy